China vs Sub-Saharan Africa (IDA & IBRD countries): Immunization, HepB3
China
96.0%
in 2024
Sub-Saharan Africa (IDA & IBRD countries)
74.0%
in 2024
China rank
42nd
Sub-Saharan Africa (IDA & IBRD countries) rank
41st
Immunization, HepB3 over time
- China
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
China currently reports 96.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 22.0%.
That makes China's figure about 1.3 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 25 years both countries report, China has been ahead every year.
China ranks 42nd and Sub-Saharan Africa (IDA & IBRD countries) ranks 41st of 188 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.0% | 37.2% | 43.8% | China |
| 2010s | 99.0% | 71.2% | 27.8% | China |
| 2020s | 97.8% | 73.4% | 24.4% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, China or Sub-Saharan Africa (IDA & IBRD countries)?
- China, at 96.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hepb3 between China and Sub-Saharan Africa (IDA & IBRD countries)?
- 22.0%, with China ahead.
- How many years of comparable data are there for China and Sub-Saharan Africa (IDA & IBRD countries)?
- 25 years are reported by both, from 2000 to 2024.
- How do China and Sub-Saharan Africa (IDA & IBRD countries) rank globally for immunization, hepb3?
- China ranks 42nd and Sub-Saharan Africa (IDA & IBRD countries) ranks 41st of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.